1Kugiyama K, Ota Y, Sugiyama S, et al. Prognostic value of plasma levels of secretory type Ⅱ phospholipase A2 in patients with unstable angina pectoris [J]. Am J Cardiol, 2000, 86 (7) : 718- 722.
2Auer J, Berent R, Lassnig E, et al. C-reactive protein and coronary artery disease [J]. Jpn Heart J, 2002, 43(6): 607-619.
3Webb NR, Bostrom MA, Szilvassy SJ, et al. Macrophage-expressed group ⅡA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice [J]. Arterioscler Thromb Vase Biol, 2003, 23(2), 263-268.
4Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J]. N Engl J Med, 2004, 350(14): 1387- 1397.
5Wiklund O, Mattsson-Hulten L, Hurt-Camejo E, et al. Effects of simvastatin and atorvastatin on inflammation markers in plasma [J]. J Intern Med, 2002, 251(4): 338-347.
